XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.4

Stockholders’ Equity (Tables)

9 Months Ended

Nov. 30, 2024

Equity [Abstract]

Schedule of Stock Option Activity

Option activity for the nine months ended November 30, 2024 and the year ended February 29, 2024 was as follows:

 Schedule of Stock Option Activity

		Options				Weighted Average Exercise Price ($)				Weighted Average Remaining Contractual Life (Yrs.)				Aggregate Intrinsic Value ($)
Options outstanding at February 28, 2023			-				-				-				-
Options assumed pursuant to reverse acquisition			86,642				61.43				2.68				-
Granted			-				-				-				-
Exercised			-				-				-				-
Forfeited or cancelled			(1,342	)			120.87				-				-
Options outstanding at February 29, 2024			85,300				60.50				2.52				-
Granted			-				-				-				-
Exercised			-				-				-				-
Forfeited or cancelled			(6,433	)			87.13				-				-
Options outstanding November 30, 2024			78,867				58.18				1.78				-
Options expected to vest in the future as of November 30, 2024			721				41.43				2.71				-
Options exercisable at November 30, 2024			78,146				58.33				1.78				-
Options vested, exercisable, and options expected to vest at November 30, 2024			78,867				58.18				1.78				-

Schedule of Stock Appreciation Rights Activity

SARs activity for the nine months ended November 30, 2024 and the year ended February 29, 2024 was as follows:

 Schedule of Stock Appreciation Rights Activity

		SARs				Weighted Average Exercise Price ($)				Weighted Average Remaining Contractual Life (Yrs.)				Aggregate Intrinsic Value ($)
SARs outstanding at February 28, 2023			-				-				-				-
SARs assumed pursuant to reverse acquisition			40,390				44.77				2.99				-
Exercised			-				-				-				-
Forfeited or cancelled			-				-				-				-
SARs outstanding at February 29, 2024			40,390				44.77				2.99				-
Granted			-				-				-				-
Exercised			-				-				-				-
Forfeited or cancelled			(167	)			37.40				-				-
SARs outstanding November 30, 2024			40,223				44.80				2.23				-
SARs expected to vest in the future as of November 30, 2024			5,429				28.55				2.59				-
SARs exercisable at November 30, 2024			34,794				47.33				2.18				-
SARs vested, exercisable, and SARs expected to vest at November 30, 2024			40,223				44.80				2.23				-

Schedule of Warrant Activity

Warrant activity for the nine months ended November 30, 2024 and the year ended February 29, 2024 was as follows:

 Schedule of Warrant Activity

		Warrants				Weighted Average Exercise Price ($)				Weighted Average Remaining Contractual Life (Yrs.)
Warrants outstanding at February 28, 2023			-				-				-
Warrants assumed pursuant to reverse acquisition			217,593				21,01				1.86
Granted			268,572				3.02				2.17
Exercised			-				-				-
Forfeited or cancelled			-				-				-
Warrants outstanding at February 29, 2024			486,165				9.94				1.96
Granted			196,774				3.18				1.99
Exercised			-				-				-
Forfeited or cancelled			(3,202	)			108.37				-
Warrants outstanding at November 30, 2024			679,737				6.52				1.98

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration